Influenza diagnosis and treatment in children: a
review of studies on clinically useful tests and antiviral treatment for
influenza
TIMOTHY M. UYEKI, MD, MPH, MPP
EDITED BY LARRY K. PICKERING, M.D.
Background.
Prompt testing for influenza can help guide
clinical management of patients with suspected influenza. Three antiviral
medications, amantadine, oseltamivir and zanamivir, are approved for treatment
of influenza in children. Rimantadine and ribavirin have also been used.
Objectives.
To review the published evidence on clinically
useful diagnostic tests and antiviral treatment for influenza virus infections
in children.
Methods.
Studies published from 1966 through September
2002 were reviewed on clinical diagnosis, immunofluorescence and rapid
influenza tests and on antiviral treatment of influenza virus infections among
pediatric populations.
Results.
No studies assessed the accuracy of clinical
diagnosis of influenza in children compared with viral culture. Compared with
viral culture, direct immunofluorescence antibody and indirect
immunofluorescence antibody tests for influenza had fair to moderate median
sensitivities and high median specificities, whereas rapid influenza
diagnostic tests had moderate median sensitivities and moderately high median
specificities. No randomized, placebo-controlled studies were found of
amantadine or rimantadine for treatment of influenza A. In a few separate
controlled studies, oseltamivir, zanamivir and ribavirin each reduced symptom
duration of influenza compared with placebo.
Conclusions.
Additional data are needed about the accuracy of
clinical diagnosis of influenza in children. Although direct
immunofluorescence antibody staining, indirect immunofluorescence antibody
staining and rapid tests are moderately to reasonably accurate in detecting
influenza virus infections in children, physicians should use clinical
judgment and local surveillance data about circulating influenza viruses when
interpreting test results. Further controlled studies of the efficacy, adverse
effects and emergence of antiviral resistance during treatment of influenza
are needed for all of the antiviral drugs.
Key words:
Influenza; children; influenza antivirals;
direct fluorescence assay; in direct fluorescence assay; rapid influenza;
diagnostic tests
From the Influenza Branch, Division of Viral
and Rickettsial Diseases, National Center for Infectious Diseases, Centers
for Disease Control and Prevention, Atlanta, GA.
Accepted for publication Nov. 4, 2002.
Address for reprints: Dr. Tim Uyeki, MS A-32,
Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA
30333. Fax 404-639-3866; E-mail tuyeki@cdc.gov.
ALL INFORMATION, DATA, AND
MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION
PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS
OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR
LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND
COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH
YOUR HEALTH CARE PROVIDER.
"A foolish faith in authority is the worst enemy of truth."
-- Albert Einstein, letter to a friend, 1901
"I know of no safe depository of the ultimate powers of the society but the people themselves, and if we think them not enlightened enough to exercise control with a wholesome discretion, the remedy is not to take it from them, but to inform their discretion by education."
-- Thomas Jefferson, letter to William C. Jarvis, September 28, 1820
"What's the point of vaccination if it doesn't protect you from the unvaccinated?"
-- Sandy Gottstein
"Who gets to decide what the greater good is and how many will be sacrificed to it?"